Abrotanum
- Manufacturer
- Hahnemann Laboratories, Inc.
- Effective date
- 2025-01-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 9
- Source
- full-release
- Hydrated at
- 2026-06-01 02:30:33
Label at a glance#
ProductAbrotanum
Active ingredientARTEMISIA ABROTANUM FLOWERING TOP
Label structure1 sections
Label contents#
Full prescribing information#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63545-713-02 | 2022-07-27 | C162847 | 48780-1 | ba0f9c33-3ee2-a910-e053-dadaa90a0b85 | 99eefa29-21f2-7fb9-e053-2995a90afb60 |
| 63545-713-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3ee2-a910-e053-dadaa90a0b85 | 99eefa29-21f2-7fb9-e053-2995a90afb60 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63545-713-02 | Abrotanum | 500 in 1 VIAL, GLASS | PELLET | 500 | 9 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Abrotanum
- ARTEMISIA ABROTANUM FLOWERING TOP
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 63545-713 | 63545-713-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARTEMISIA ABROTANUM FLOWERING TOP | QG07G580U0 | ACTIB |
| SUCROSE | C151H8M554 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99ef26d5-de23-1cae-e053-2995a90a3ffd | 2025-01-09 | 63545-713 | |
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99eefa29-21f2-7fb9-e053-2995a90afb60 | 2025-01-09 | 63545-713-02 63545-713 63545071302 2b4a2c07-24ce-ac03-e063-6394a90a3535 99eefa29-21f2-7fb9-e053-2995a90afb60 | |
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99eeeff1-75db-5226-e053-2995a90a42ab | 2025-01-09 | 63545-713 | |
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99ef0e70-5722-da4a-e053-2995a90aabc0 | 2025-01-09 | 63545-713 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
